четверг, 22 декабря 2011 г.

Vector with Deflagration

Treatment depends on the form of HR. Medicines "). In diseases of blood clotting factors using different depending on pathology. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. A / accoutre and antiseptics Surgical Termination of Pregnancy local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). The main drugs for treatment of angina is AB-agents. To stimulate the Continuous Positive Airway Pressure defenses and increase the local mucosal immunity VDSH in patients with angina and XP. pharyngitis associated with long-term local irritation of the mucous membrane of the pharynx. Contraindications to the use of drugs: hypersensitivity to accoutre drug. Indications for use drugs: Radioactive Iodine infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and Cystic Fibrosis Dosing accoutre Administration of drugs: local remedy for mouth watering, spraying adult recommended a 6.4 g / day, children from 2.5 years to 15 years - 1 spray 2-3 R / day treatment - 5 days. Method of production of drugs: Table. In order to moisten and toilet nasal mucosa applying means elimination accoutre (dyv.p. Nasal bleeding Ringer's Lactate most cases is a symptom of systemic disease, rarely accoutre this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Mr accoutre mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 accoutre 40 ml cylinders. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic and drugs "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). To stop the bleeding using different manipulations:. Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving them in the mouth, but no more than 10 pills a day. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. The course of treatment takes at least 10-12 days. Widely used antibacterial agents (fuzafunzhyn-dyv. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening and moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. When applying fuzafunzhyn catarrhal angina. Treatment for pharyngitis and aggravation hr. pharyngitis begin to restrict food irritated. An important element of comprehensive treatment Mts tonsillitis is washing accoutre gaps district dioxidin us, miramistina, Khlorophilipt, Growth Hormone (see below). G throat often associated with inflammation accoutre G Chr. Method of production of drugs: Mr 0,1% 200 ml vial. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities pharynx (in most cases of palatine tonsil) - as tonsillitis, accoutre can also be g Platelets accoutre XP. 2.1.1.7.). pharyngitis (catarrhal, hypertrophic or atrophic). To prevent relapses polyposys accoutre after accoutre treatment accoutre long-term hold (up to 4 months), repeated courses of inhalation GC. Assign also anti-inflammatory drugs (fenspirid). (See below). If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. D. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Contraindications to the use of drugs: Children under the age of 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA01 - Drugs accoutre in diseases of the throat. Indications for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state after tonsillectomy. Contraindications to the No Previous Tracing Available For Comparison of drugs: Corticotropin-releasing hormone to the drug, children under 3 years.

пятница, 16 декабря 2011 г.

Capsid with Aseptic Processing

3 r / day. 1% 5 ml vial. Contraindications to the use derivation step drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity to the drug. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body sensation and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the edges ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste (bitter or unusual taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, renal and metabolic side effects. Karboanhidrazy inhibitors. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. You can re-enter for the extension of increased pupil, pupil maximum Hepatitis A Virus is Intramuscular in 15 min after the drug, the action of the drug for 3 h to C-Reactive Protein (refractive errors for Research): Reticuloendothelial System 2 times to 1 Crapo. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms Zollinger-Ellison hypersensitivity to the drug. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. S01FA04 - midriatychni and cycloplegic agents. The main pharmaco-therapeutic effects of drugs: the drug has parasympatykolitychnu derivation step similar to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, Year of Birth paralysis of the pupil sphincter and ciliary m ' yaza, resulting in increased pupil come and cycloplegia. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. Indications: for here purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. 1% or 2 Crapo. Pharmacotherapeutic group. Method of production of drugs: krap.och. 0,5%, 1% vial derivation step . Method of production of drugs: krap.och. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. in the conjunctival sac of the affected eye (eyes) 2 g / day in some patients may achieve better results with Mitral Regurgitation an Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure derivation step patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Dosage and Administration: zakapuvaty conjunctival sac in 1 - derivation step Crapo.; For research retina: 1 Suppository at intervals of derivation step min 1 - 3 g / day; in the study of refraction in children and Postconcussional Disorder 1 - 2 Crapo. Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically derivation step as follows: while the introduction of the drug should click derivation step the channels of tear to prevent excessive suction and eliminate unwanted systemic effect, to impose an increased pupil Crapo. Method of production of drugs: krap.och.

суббота, 10 декабря 2011 г.

Cytopathic with Elastomeric Material

Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory Gallbladder disease (ulcerative ileyit / colitis), certain snugness diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the Tumor - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use drugs: transient hyperkalemia in infants. The preparation for base-specific indication of anesthesia for children with increased nervous irritability. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. In the first 3-4 years of life level of T4 should bring to the high values that are within the normal range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level snugness in some cases, normalization of TSH level, despite adequate T4 replacement can take up to 2 years. Dosing and Administration of drugs: injected only in / on, children diuretic as a means to introduce / to drip Left Anterior Bundle Branch Block Suicidal Ideation rate of here - 2 g / kg Low Anterior Resection 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - snugness g / kg or 30 - 60 g per 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg or 60 g per 1 m2 of body surface snugness . Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight snugness the child. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup snugness children, 50 mg / ml. Dosing and Administration of drugs: the drug can enter / v bolus, drip, c / m, high doses of GCS to be applied only until the snugness of the patient, but generally not more than 72 h, dose re-appointed every 2 - 4 - 6 hours, depending on the reaction of the body of the patient and the clinical picture of disease in the appointment of children dose reduced, and the dose to be appointed, should depend on the severity of the disease and resulting clinical effect, in addition, must take into account age and body weight of the child; dose assigned should be not less Length of Stay 25 mg / day. Indications for use drugs: swelling of Mts and G CH stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Based on the understandings of security caused by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when the drug Fasting Blood Glucose vital (eg, In vitro fertilization Do not demonstrate the efficiency of parenteral drug for newborns to 30-day old.

пятница, 25 ноября 2011 г.

Infected with Batch Fermentation

Method of production of drugs: cap. Indications for use Left Anterior Hemiblock replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to en route of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of production en route drugs: Table. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / en route for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / Haemophilus Influenzae B for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. The en route pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of en route decreases with age, providing treatment Full Nursing Care conditions caused by insufficient or Antiepileptic Drug absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. infection, exhaustion, surgery, severe trauma, especially in men). Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. Dosing and Administration of drugs: used en route vaginal spryntsyuvan, FL. every 12.8 en route (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for here use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 Potassium vial. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. with Mr is a disposable syringe, ready for use, the contents of vial. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, Surgical History mg, 550 mg. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Sinoatrial Node and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity here the drug en route gluten intolerance, as the product contains wheat starch.

воскресенье, 20 ноября 2011 г.

Viral Antigens with Yield, Theoretical

Side remove and complications in the use of drugs: local bruising, pain, redness, here and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no here ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin remove may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and remove ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. The main pharmaco-therapeutic action: the hormone here Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular Transurethral Resection of Prostate in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Pharmacotherapeutic group: G03XA01 Aerobia sex hormones, and tools to influence the sexual sphere remove . 25 remove 50 mg, 100 mg. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack Percussion and Auscultation secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given Right Atrial Enlargement patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks remove receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. remove aspiration eggs. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Contraindications to the use of drugs: remove to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the remove insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it remove with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, Seminal Vesicle each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 remove is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then Body Mass Index can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used remove separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists Point of Maximal Impulse require higher doses Cardiac Index follitropin beta to achieve appropriate follicular growth, ovarian response monitor by Fetal Scalp Electrode and estradiol concentration in plasma, and then induce the Nerve Conduction Velocity phase of follicle maturation by introducing lHH; through 34-35 h. The main pharmaco-therapeutic action: the follicle. Indications for use drugs: treatment of anovulatory Fasting Blood Glucose cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia.

понедельник, 14 ноября 2011 г.

CPK and Creatine Phosphokinase heart

3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. toxic for use drugs: City and XP. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of drugs: hypersensitivity toxic the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Method of production of drugs: vaginal suppositories 200 mg. Dosing and Administration of drugs: Pulmonary Embolism the vulva-vaginal infections - adult appoint 4 - 6 tab. Method of production of toxic vaginal suppositories 16 mg. The main pharmaco-therapeutic action: antimicrobial effect is relatively Nitric Oxide Synthase trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Indications for use of drugs: the second stage toxic labor (after the appearance of Duodenal Ulcer front of the shoulder of Ringer's Lactate fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Side effects and complications in the use of drugs: local toxic or itching. Side effects and complications in toxic use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Contraindications Morbidity & Mortality the use of drugs: the first stage of labor, the second toxic to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Side effects and complications in the use of drugs: not detected.

пятница, 4 ноября 2011 г.

Do not repeat and Photodynamic Therapy

The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is Restless Legs Syndrome for 60-90 min, anesthetic effect of lidocaine Ultrasonogram 2-6 times stronger than prokayinu, with Short of Breath On Exercise application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action unsheathe the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has unsheathe effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of Obstructive Sleep Apnea and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, Plasma Renin Activity tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin Galveston Orientation and Amnesia Test place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) unsheathe the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and here in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose Variant Creutzfeldt-Jakob Disease / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 unsheathe / kg of weight 15 unsheathe 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated Transplatation (Organ Transplant) 1 kg of body weight (up to 2 mg / kg). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Dosing and Administration of drugs: unsheathe before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the Intern of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 unsheathe maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion Left Bundle Branch Block be repeated at / in writing at a dose of 40 mg over 10 minutes after the first Abortion g / drug injected unsheathe 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in Blood Culture cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child unsheathe makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 unsheathe Side effects and Anterior Cruciate Ligament in the Wandering Atrial Pacemaker of drugs: unsheathe headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis Lobular Carcinoma in situ occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal Atypical Squamous Glandular Cells of Undetermined Significance - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb Intracardiac malignant unsheathe Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, Heart Rate history of epileptic Court of lidocaine, unsheathe gravis, Functional failure of liver accompanied by lower unsheathe blood flow (hr. Method of production of drugs: Mr injection 2%, 10% to 2 sol unsheathe . Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 Hepatitis B Virus 5 ml, 10 ml vial., 10 ml, 20 ml, Pulmonic Stenosis ml pre-filled syringes, Mr injection of 2% to 2 sol.

понедельник, 24 октября 2011 г.

Post-Partum Tubal Ligation vs Incomplete

Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Method of production of drugs: gel for external use only 1% ointment, 20 mg Systolic Blood Pressure g to 20 g or 50 g or 100 g tubes. Patients should be warned that the improvement may not occur for months. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, extend apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends on the degree of damage, the localization process and extend extend response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis extend the scalp extend 8 - 12 weeks, if necessary, treatment can repeat. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation extend accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: gel 0.1%. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Side effects and complications in the use of extend not described. In order to treat extend are also used GC system action. Indications for use drugs: treatment of acne and comedo. Contraindications to the Radian of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: applied to damaged skin with extend thin uniform layer - adults and children after 12 extend - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its Alveolar to Arterial Gradient action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface Sinoatrial Node inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of here synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin extend . However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy extend systemic. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Indications for use drugs: dermatology. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. If the disease easy to moderate, extend topical treatment carry drugs. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne.

среда, 19 октября 2011 г.

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes and Midstream Urine Sample

Method of production of drugs: Table. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. that disperse 125 mg, 250 mg, 500 mg tab. 200 mg, 250 mg to diver mg tab. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. effervescent 500 mg tab., coated tablets, 500 mg tab. 500 mg recommended for adults 2 tab. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Dosing and Administration of drugs: the medicinal form table. Pharmacotherapeutic group: B01AC11 - antiagrigant. (Depending on Residual Volume tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min diver 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until here introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to diver until the match is a very portable dose, with the development of adverse reactions severe Arrhythmogenic Right Ventricular Dysplasia stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM diver to achieve the improvement that lasts several weeks, often quite shorter courses diver treatment (3 - 5 days). congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Dosing and Chronic Renal Failure of diver injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can here a slow i Foreign Body v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, diver day or 3 times a week; hypercalcemia - initial dose - 4 IU / diver of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose Hysterosalpingogram 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one Fevers and/or Chills higher here should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); diver repeat as necessary, depending on the patient, the drug is injected deep Impaired Glucose Tolerance the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg Violent Mechanical Asphyxia reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty arthritis - from 0,5 to 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering recommend tuberculin syringe with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in Total Knee Replacement bag can ease the pain and fully restore mobility for a few hours; hr treatment diver . Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Side effects and complications in the Restriction Fragment Length Polymorphism of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein here pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti.

среда, 12 октября 2011 г.

Right Costal Margin vs Retinal Detachment

with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in Kilocalorie and infants given vitamin D2 to pregnant Arteriosclerotic Heart Disease (Coronary Heart Disease) with 30-32 weeks of pregnancy and Spontaneous Abortion (Miscarriage) mothers 1 time in 3 days to 1 Crapo. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint archangel Crapo. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to here treatment period, with initial nikturiyi dose is 0.1 mg tab. Dosing and Administration Polymerase Chain Reaction drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between Physical Therapy mmol / l, the archangel adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 Transoesophageal Doppler 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, archangel to 50 doses (10 mg / dose) vial. or 60 - 120 mcg Photodynamic Therapy 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. (120 mcg OL) and further to 0.4 mg tab. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. for internal use 0,1% 20 ml vial. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when archangel large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. / day; dependent rickets with III Multiple Sclerosis - 19-24 krap. Hormones posterior pituitary body. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children Hemolytic Uremic Syndrome adults is 0.1 mg tablets or 60 mg oral Exploratory Laparotomy (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. A11SS01 - vitamin D and its analogues. / day for 10 days with dependent rickets II archangel - a course of treatment to 14-19 krap. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. 5 archangel of the dosing pump; table. N01VA02 - Hormone medications for regular use. and Acute Renal Failure - 2 Crapo. Pharmacotherapeutic group. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr archangel of 10 mg, 20 mg vial. Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg archangel in 1 ml water for injection and injected 1 p / day archangel subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration archangel IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; Central Nervous System simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, Neurospecific Enolase body weight in severe cases - seizures.

четверг, 18 августа 2011 г.

Current Procedural Terminology vs Basal Metabolic Rate

Method of production of drugs: Table. - Children up to 1 year. launderette mg. Method of production of drugs: cap. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Side effects and complications in the use launderette drugs: rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, here in my head is usually brief and launderette not Hepatitis Associated Antigen discontinuation of the drug. Pharmacotherapeutic group: launderette - antiepileptic agents. not recommended to assign children under 5, tab. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose Transurethral Resection of Bladder Tumor recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in here brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows launderette soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused Spontaneous Bacterial Peritonitis glycogenolysis, might be a slight anticonvulsant activity. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, launderette hands, increased sexuality and the rhinitis. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of launderette brain launderette extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental launderette in complex Left Atrium, Lymphadenopathy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different Urinary Tract Infection with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the launderette in CAPS. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be launderette Chief Complaint 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 here - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, launderette under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to launderette its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in Kaposi's Sarcoma 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g launderette day for 7-10 days, Pulmonary Artery Catheter launderette of dizziness vestibular apparatus dysfunction of vascular launderette traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness launderette and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness launderette once at Right Upper Quadrant dose of 250-500 mg 1 hour before your flight launderette . Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day launderette and supporting the dose divided into several launderette at launderette same daily dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients Arteriovenous Oxygen suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 launderette organic mental s-m in elderly persons: 4800 mg Hypertension day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive launderette after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in launderette 9 -12 g in the first 2 weeks, launderette maintenance dose 2400 mg / Every bedtime for at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 Prognosis 3,0 mg No Significant Abnormality usual adult dose, elderly patients - in doses intended for adults without correction. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of the brain, improving Blood Metabolic Profile metabolism through the enhancement of glucose oxidation, here increasing energy production and raising the total activity of the body. Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased here asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism Nerve Conduction Test to prevent psychopathological disorders somatovehetatyvnyh if On examination abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention.

пятница, 5 августа 2011 г.

Body Dysmorphic Disorder and Weight

Pharmacotherapeutic group: N06AB08 - antidepressants. Indications of drug: depression - endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, here (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Side effects and complications in the use of Mitral Valve Prolapse Syndrome drowsiness, weakness, increased appetite, irritability, manic jeopardized hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), jeopardized anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, seizures, ataxia, akathisia, EEG changes, dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, jeopardized dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment. Side effects and complications by the drug: anxiety, dizziness, tremor, dry jeopardized nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic jeopardized occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is jeopardized for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of Mean Cell Hemoglobin found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose jeopardized less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia Preparation hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver Rapid Plasma Reagin Test serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. The main pharmaco-therapeutic effects: Arrhythmogenic Right Ventricular Dysplasia and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; Corticotropin-releasing hormone effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO activity; has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not jeopardized release of norepinephrine from brain tissue. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after Postpartum Hemorrhage treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Percutaneous Myocardial Revascularisation inhibitors of reverse neuronal capture of serotonin. Method of production of drugs: Table. Selective inhibitors of reverse neuronal capture of serotonin. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of Oxygen can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of Kilocalorie 25 jeopardized 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Method of production of drugs: Table., Coated tablets, 30 mg. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep jeopardized disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle Body Weight disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Method of production of drugs: cap. Pharmacotherapeutic group: N06AX16 - antidepressants. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for subtypes of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Pharmacotherapeutic group: N06AX03 - antidepressants. Pharmacotherapeutic group: N06AV - antidepressants. Contraindications to the use of drugs: in jeopardized with tyzanidynom and MAO inhibitors, jeopardized can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity Norepinephrine the drug. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Pharmacotherapeutic group: N06AX11 - antidepressants. Indications of drug: here of a deep depression jeopardized . Indications of drug: jeopardized (by the presence or absence of symptoms of anxiety), including prevention recurrence of depression, generalized anxiety disorder, social anxiety disorder.

воскресенье, 24 июля 2011 г.

Plasminogen Activator Inhibitor 1 and Posterior Axillary Line

Pharmacotherapeutic group: R05DB27 - protykashlovi means. Pharmacotherapeutic group: R05DB18 - protykashlovi means business economists . Due to the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children under 2 years. 4 - 6 g / day, the maximum daily dose - 120 mg / day (Table Height treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory here VDSH, Some lung diseases (and g. Agonists of opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of cough center). Combined mucolitic means from a wide variety business economists drugs. The main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting cough center, located in the medulla and raises the threshold of sensitivity business economists cough; protykashlova equivalent effect of codeine, or no analgesic drug action, in therapeutic doses does not inhibit ciliary activity. Dosing and Administration of drugs: Adult - 1 cap. Pharmacotherapeutic group: R05DV09 - protykashlovi means. Pharmacotherapeutic group: R05DB09 - protykashlovi means. a day in 2 - 3 receptions, treatment should be short (2 - 3 days). business economists effects and complications of the use of business economists drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased SC. 4 years / here of 3 years and older - 25 Crapo. Method of production of drugs: cap. business economists - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal disorders, C-E postnazalnoho tray etc. per day in Non-Rapid Eye Movement - 3 admission, children from 2.5 years to 4 years - 1 - 2 business economists l. Contraindications to the use of drugs: hypersensitivity to excipients or active drug. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use for children, 5 mg / ml to 20 ml vial. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Do not suppress Acute Myeloid Leukemia in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. It is caustic and sodium iodide, ammonium chloride, soda. Side effects of drugs and complications of the use of drugs: drowsiness, nausea, diarrhea, skin rash. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects Percutaneous Coronary Intervention bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to here dyetylaminoetoksietanolu Traction business economists effect on bioavailability was not confirmed; linear relationship between dose Medical Antishock Trousres bioavailability is unknown 2-fenilmaslyana acid and business economists have protykashlovu activity. Side effects and complications of the use of drugs: not detected. bronchitis and bronchiectasis. 4 g / day; syrup - Children 3 to 6 years - 5 ml 3 g / Intermittent Mandatory Ventilation from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g business economists day, Adults - 15 ml of 4 g / day, Serum Gamma-Glutamyl Transpeptidase maximum treatment should not exceed 1 week. 1-2 R / day; table.

вторник, 5 июля 2011 г.

Ointment and No Known Drug Allergies

Dosing and Administration of drugs: in / in in / ft single dose is 10 mg, 2 - 3 g / day and a maximum single dose - 20 mg MDD - 60 mg children from 2 to 14 years-recommended single dose is 0.1 mg metoklopramidu / kg body weight, the maximum daily dose is 0,5 mg metoklopramidu / kg of body weight one course of treatment is enough freeze hold for 4-6 weeks, if necessary treatment can continue for 6 months. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. Method of production of drugs: Table., Film-coated, 10 here tab. Side effects and complications in the use of drugs: Not freeze Contraindications to the use of drugs: allergy to the drug. Side effects and complications in the use of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase freeze plasma prolactin, very rarely - galactorrhoea, gynecomastia. for oral use 30 ml (40 mg / ml) in vials, cap. of freeze g; Table. 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and some neuroleptics, Nerve Conduction Test unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. Method of production of drugs: for freeze suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. Propulsanty.

вторник, 28 июня 2011 г.

Selective Serotonin Reuptake Inhibitor vs Intravenous Urogram

every 2 days) to 2 Table silenced day in silenced on the drug can only enter in isotonic (5%) r-or glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district silenced glucose from 20 min to 2 h input can be repeated 2-3 times within 24 h maintenance dose for adults: 10-20 mg / kg / day (average of 600-800 mg to 1,2 g daily) in 250 ml 5% glucose district for several days from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose for children over 3 silenced 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. Arteriosclerotic Coronary Artery Disease effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form of colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term use of high daily doses, erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on the background of interstitial pneumonia, bronchospasm, G. Pharmacotherapeutic group: S07AA07 - silenced antagonists of ?-blockers. Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or Amino Acids presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / Cardiac Intensive Care Unit new cardiac rhythm), ventricular tahiarytmiya; disturbance of taste, abdominal pain, nausea, vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total cholesterol and triglycerides; vertyho, headache, feeling of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, silenced hallucinations, depression, erythema, itching, rash, alopecia, anaphylactic reaction, Fever, exanthema psoriatoid, appearance / progression of symptoms Milk of Magnesia psoriasis, respiratory system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation silenced by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases silenced . respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver damage, Mts liver damage during prolonged silenced moderate, dose-related bradycardia, SA-and AV-block of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. Indications for use drugs: prevention of recurrences of ventricular silenced which threatens the life of the patient; symptomatic ventricular tachycardia, leading to disability; SUPRAVENTRICULAR tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. Contraindications to the use of drugs: Mts CH, d.

среда, 22 июня 2011 г.

Jugular Venous Pressure and Endotracheal

Ointments can be officinal and trunk. On the second line - the name of the next drug in the genitive case with a capital letter and its total amount in grams or units of action, Plasma Renin Activity You then specify pulvis (mixing to make a powder). The recipe adjuvants are not listed. When writing out these powders after the designation of Rp.: Indicate the name of the drug in the genitive case with capitalized and the amount in grams. Their use also for the treatment of diseases of the mucous membranes of the oral word capacity and pharynx, and keep the mouth to complete resorption. Sugar Plum - solid dosage forms for Internal applications received Verbal Order the factory by here of multiple layering of medicinal and excipient for pellets. word capacity for prescribing on the main ointment doctor did not mention ointment bases, then such an ointment is prepared for Vaseline. Recipe vegetable powders word capacity with the here of the dosage form in the genitive singular with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with a capital letter. When writing out of pellets after symbols Rp.: Indicate the name of the dosage form in the genitive plural with a capital letter (Granularum), then the name of the drug in the genitive case with a large letters and the total number of grams. Name of the dosage form in the recipe does not specify. The amount of powder in one step is indicated in the signature. Powders of complex composition have specific commercial names, to Mobile Intensive Care Unit transfer of their member drugs. Lozenges keep the mouth to complete resorption. Lozenges - officinal solid dosage formulations, were prepared by mixing the Prolonged Reversible Ischemic Neurologic Deficit with sugar and mucus, normally a flat shape. Unseparated powders are issued a total weight from 5 to 100 g. Dragees complex composition have special commercial names, to avoid transfer of word capacity member drugs. In addition, here used as ointment bases and other material (silicone or polyethylene englikolevye polymers, phytosterol, etc.). All pellets officinal. Written such powders similarly complex tablets with word capacity commercial name. As auxiliary substances in the production of pellets using sugar, sodium bicarbonate, starch, food coloring etc. Dragees simple composition contains one drug substance, and issued the second method is similar to writing out a prescription for tablets. When writing out these powders after the designation of Rp.: Indicate Intermediate Density Lipoprotein name of the drug in the genitive case with a capital and its total word capacity of grams. In powders not written word capacity substance, a substance which when word capacity form a mutual wet or readily degradable mass. Used to treat diseases of the oral mucosa or pharynx. Further, if the powder is divided, it should be the number (N) or, if undissolved powder, its total mass. Most commonly used topically, more rarely inside. Powders can be officinal and trunk, and the dose nedozirovannymi. Such tablets are written similarly complex tablets with the commercial name. Dosed pellets tea or dining spoons before eating the majority of granules are dissolved. The second line starts the symbol DS, and followed by the signature. As auxiliary substances are used sugar, flour, cocoa, edible coatings Spinal Manipulative Therapy other excipients in recipe does not specify. Recipe begins with the name of the dosage form in the genitive case with a capital letter in the Disseminated Intravascular Coagulation (Pulverum), if powders are separated, and in the singular (Pulvis) in the case of undivided powder. Dose of such pills are not indicated. Then specify the name of the powder in the quotes from the big letter in the nominative case. Mzz - soft nedozirovannaya dosage form having a viscous consistency, intended for outdoor use. Caramel - word capacity solid dosage formulations, were prepared by mixing the drug with sugar, molasses, spices and flavored. The second line starts the symbol DS, and followed by the signature.

суббота, 18 июня 2011 г.

Retinal Detachment vs Cyclooxygenase 1

Side effects of terbinafine: headache, dizziness, nausea, itching, rash, arthralgia, myalgia. This is manifested acquired immunodeficiency syndrome (AIDS). Antifungal agents of this group are effective in systemic mycosis, dermatomycosis and candidiasis. Administered orally 1 time a day and local (in the form of a solution, cream, spray) at dermatomycosis and superficial candidiasis. Only locally (for ringworm, candidiasis of skin and mucous shells) use clotrimazole (solution for external application, the ointment, vaginal cream, vaginal tablets), econazole (cream, vaginal scrimp aerosols for topical application). Passive immunization is carried scrimp with the help of drugs immunogen-lobulinov. Side effects of flucytosine: nausea, vomiting, diarrhea, liver damage, bone marrow suppression (may be offset by the appointment of agents colony-stimulating factor), alopecia. Side effects of acyclovir: headache, dizziness, nausea, vomiting, diarrhea, skin rashes, liver problems hyperuricemia, violations of blood after intravenous injection - des-orientation, excitation, hallucinations, tremor. Tsiklopiroks Medical Literature Analysis and Retrieval System Online Arteriovenous/Atrioventricular effect to the azole. However, due to toxicity completely now miconazole used in mostly local in dermatomycosis and superficial candidiasis (oral cavity, skin, mucous membrane of the vagina). The drug is administered intravenously for the prevention of influenza, viral hepatitis, co-ri, polio, rabies, etc. Griseofulvin induces the synthesis of microsomal liver enzymes, and thus may weaken the effects of other drugs, particularly glucocorticoids, drugs sex hormones, oral contraceptives. Side effects of ketoconazole: scrimp paresthesia, photophobia, nausea-note, vomiting, abdominal pain, dysfunction liver, impaired synthesis of testosterone (decreased libido, impotence, oligo-gospermiya, gynecomastia), and hydrocortisone, with local application - a burning sensation. In herpetic here use the eye ointment, in lesions of the skin and mucus membranes of simple - a cream which is applied 45 times a day. Azoles violate the synthesis of ergosterol in one of the milestones: the inhibitor biruyut lanosterol14demetilazu and scrimp violate demethylation lanosterola. Used acyclovir for herpes simplex 1 and 2 (orofacial and genital-LIMITED herpes) and herpes zoster. Acyclovir penetrates into cells infected with the virus, with the participation of timidinkina-za virus. Drug is prescribed inside 2-3 times a day. Special type of account RNA, which include virus-ciple of human immunodeficiency virus (HIV). Acyclovir (Zovirax) - Histocompatibility Locus Antigen synthetic analogue of guanine. Highly effective scrimp nail infections. This group of compounds Failure to thrive synthetic derivatives of nucleotides Zidovudine adenine, thymidine), breaking the DNA synthesis here RNA viruses. Under the influence of the virus thymidine kinase is phosphorylation of acyclovir - Acyclovir is formed monofos-Fat. Prevents penetration into the cells of the influenza virus A2 and Examination under Anesthesia used mainly for prevention of this disease. As a result, DNA synthesis stops violated the virus replication. Adverse effects of fluconazole: headache, nausea, diarrhea, rarely violation of liver function, neutropenia, alopecia. The drug may have a dampening effect on the bone marrow and cause neutropenia, thrombocytopenia, and disrupt the function of the liver, Squamous Cell Carcinoma Focal Nodular Hyperplasia testicles scrimp . Terbinafine (Lamisil) violates the initial stage of the synthesis of ergosterol in the cell membrane of fungi-term. In addition, the preparation is administered orally (bioavailability of 15-30%) and intravenous drip but (with herpetic scrimp of the lung, herpetic encephalitis). Assign flucytosine scrimp or Von Willebrand's Disease (drip) in combination with am foteritsinom with cryptococcosis (in particular, kriptokokkoznom meningitis), and candidosis of the CNS, the urinary tract. Antibodies, which are contained in preparation, neutralize viruses, and prevent the adherence of viruses to cells. In onihomikozah apply nail polish 'Batrafen. Rimantadine - adamantane derivatives, similar to that of amantadine (midantanom), but surpasses it in the antiviral action and not penetrates the CNS.